Advertisement
AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

AJPH First Look, published online ahead of print May 2, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
AJPH.2005.062745v1
96/6/1060    most recent
Right arrow Submit a response
Right arrow purchase articles
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Get other permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Feldman, J. G.
Right arrow Articles by Anastos, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feldman, J. G.
Right arrow Articles by Anastos, K.
©
American Journal of Public Health, 10.2105/AJPH.2005.062745

Research and Practice

The Association of Cigarette Smoking With HIV Prognosis Among Women in the HAART Era--A Report From the Women's Interagency HIV Study

Joseph G. Feldman 1*, Howard Minkoff 2, Michael F. Schneider 3, Stephen J. Gange 3, Mardge Cohen 4, D. Heather Watts 5, Monica Gandhi 6, Robert S. Mocharnuk 7, Kathryn Anastos 8

1 SUNY Downstate Medical center
2 Maimonides Medical center
3 John Hopkins School Public Health
4 Cook County Hospital
5 PAMA NICHD
6 University of California at San Francisco
7 Univ Sothern California,Keck School of Medicine
8 Montefiore Medical Center and Lincoln Medical and Mental Heath Center

* To whom correspondence should be addressed. E-mail: joseph.feldman{at}downstate.edu.


  Abstract

Objective. We assessed the association of cigarette smoking with the effectiveness of highly active antiretroviral therapy (HAART) among low-income women.

Methods. Data were analyzed from the Women's Interagency HIV Study, a multisite longitudinal study up to 7.9 years for 924 women representing 72% of all women who initiated HAART between July 1, 1995, and September 30, 2003.

Results. When Cox's regression was used after control for age, race, hepatitis C infection, illicit drug use, previous antiretroviral therapy, and previous AIDS, smokers on HAART had poorer viral responses (hazard ratio [HR]=0.79; 95% confidence interval [CI]=0.67, 0.93) and poorer immunologic response (HR=0.85; 95% CI=0.73, 0.99). A greater risk of virologic rebound (HR=1.39; 95% CI=1.06, 1.69) and more frequent immunologic failure (HR=1.52; 95% CI=1.18, 1.96) were also observed among smokers. There was a higher risk of death (HR=1.53; 95% CI=1.08, 2.19) and a higher risk of developing AIDS (HR=1.36; 95% CI=1.07, 1.72) but no significant difference between smokers and nonsmokers in the risk of death due to AIDS.

Conclusions. Some of the benefits provided by HAART are negated in cigarette smokers.

Key Words: HIV/AIDS, Mortality, Tobacco, Women's Health




This article has been cited by other articles:


Home page
 AJPHHome page
M. Bloch, F. Althabe, M. Onyamboko, C. Kaseba-Sata, E. E. Castilla, S. Freire, A. L. Garces, S. Parida, S. S. Goudar, M. M. Kadir, et al.
Tobacco Use and Secondhand Smoke Exposure During Pregnancy: An Investigative Survey of Women in 9 Developing Nations
Am J Public Health, October 1, 2008; 98(10): 1833 - 1840.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by the American Public Health Association